Martin Nowak, one of the world's experts on evolution and game theory, working here with bestselling science writer Roger Highfield, turns an important aspect of evolutionary theory on its head to explain why cooperation, not competition, has always been the key to the evolution of complexity. In his first book written for a wide audience, this hugely influential scientist explains his cutting-edge research into the mysteries of cooperation, from the rise of multicellular life to Good Samaritans, and from cancer treatment to the success of large companies. With wit and clarity, and an eye to its huge implications, Nowak and Highfield make the case that cooperation, not competition, is the defining human trait. "SuperCooperators "will expand our understanding of evolution and provoke debate for years to come.

Beyond The Survival of the Fittest: Why Cooperation, not Competition, is the Key to Life If life is about survival of the fittest, then why would we risk our own life to jump into a river to save a stranger? Some people argue that issues such as charity, fairness, forgiveness and cooperation are evolutionary loose ends, side issues that are of little consequence. But as Harvard's celebrated evolutionary biologist Martin Nowak explains in this groundbreaking and controversial book, cooperation is central to the four-billion-year-old puzzle of life. Indeed, it is cooperation not competition that is the defining human trait.

This groundbreaking book describes the emerging field of theoretical immunology, in particular the use of mathematical models to describe the spread of infectious diseases within patients. It reveals fascinating insights into the dynamics of viral and other infections, and the interactions between infectious agents and immune responses. Structured around the examples of HIV/AIDS and hepatitis B, Nowak and May show how mathematical models can help researchers to understand the detailed dynamics of infection and the effects of antiviral therapy. Models are developed to describe the dynamics of drug resistance, immune responses, viral evolution and mutation, and to optimise the design of therapy and vaccines.